Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA Inc.
Docket No. | Argument | Opinion | Vote | Author | Term |
---|---|---|---|---|---|
17-1229 | Dec 4, 2018 | Jan 22, 2019 | 9-0 | Thomas | OT 2018 |
Holding: The sale of an invention to a third party who is obligated to keep the invention confidential may place the invention "on sale" for purposes of the Leahy-Smith America Invents Act, which bars a person from receiving a patent on an invention that was "in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention," 35 U. S. C. "102(a)(1).
Judgment: Affirmed, 9-0, in an opinion by Justice Thomas on January 22, 2019.
SCOTUSblog Coverage
- OT2018 #16: "From Scratch" (First Mondays, January 28, 2019)
- Opinion analysis: Justices affirm ruling that secret sales of invention bar later patent (Ronald Mann, January 22, 2019)
- Argument analysis: Justices debate revised language in patent-priority statute (Ronald Mann, December 5, 2018)
- Argument preview: Of patents, prior art and secret sales (Ronald Mann, November 27, 2018)
- Court sends battles over services for same-sex couples, North Carolina gerrymandering back to lower courts (Updated) (Amy Howe, June 25, 2018)
- Petition of the day (Aurora Barnes, April 12, 2018)